Proteomic Analysis of Microvesicles Derived from Human Mesenchymal Stem Cells
Authors:
- So Jeong YunSYSo Jeong Yun
- Seong-Mi ChoiSCSeong-Mi Choi
- Daehee HwangDHDaehee Hwang
- Kwang Pyo KimKKKwang Pyo Kim
- Dong-Wook KimDKDong-Wook Kim
- 28 December 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 11 (2) , 839-849
Abstract
Mesenchymal stem cells (MSCs) have emerged as a promising means for treating degenerative or incurable diseases. Recent studies have shown that microvesicles (MVs) from MSCs (MSC-MVs) contribute to recovery of damaged tissues in animal disease models. Here, we profiled the MSC-MV proteome to investigate their therapeutic effects. LC–MS/MS analysis of MSC-MVs identified 730 MV proteins. The MSC-MV proteome included five positive and two variable known markers of MSCs, but no negative marker, as well as 43 surface receptors and signaling molecules controlling self-renewal and differentiation of MSCs. Functional enrichment analysis showed that cellular processes represented by the MSC-MV proteins include cell proliferation, adhesion, migration, and morphogenesis. Integration of MSC’s self-renewal and differentiation-related genes and the proteome of MSC-conditioned media (MSC-CM) with the MSC-MV proteome revealed potential MV protein candidates that can be associated with the therapeutic effects of MSC-MVs: (1) surface receptors (PDGFRB, EGFR, and PLAUR); (2) signaling molecules (RRAS/NRAS, MAPK1, GNA13/GNG12, CDC42, and VAV2); (3) cell adhesion (FN1, EZR, IQGAP1, CD47, integrins, and LGALS1/LGALS3); and (4) MSC-associated antigens (CD9, CD63, CD81, CD109, CD151, CD248, and CD276). Therefore, the MSC-MV proteome provides a comprehensive basis for understanding the potential of MSC-MVs to affect tissue repair and regeneration.Keywords
This publication has 57 references indexed in Scilit:
- Mesenchymal stem cells for clinical applicationVox Sanguinis, 2010
- Trafficking and differentiation of mesenchymal stem cellsJournal of Cellular Biochemistry, 2009
- Mesenchymal stem cells as trophic mediatorsJournal of Cellular Biochemistry, 2006
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsThe Lancet, 2004
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cellsJournal of Clinical Investigation, 2002
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUESTransplantation, 1974